Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Interest Coverage : 13.48 (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Tianjin Pharmaceutical Da Ren Tang Group Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Tianjin Pharmaceutical Da Ren Tang Group's Operating Income for the three months ended in Dec. 2023 was ¥108 Mil. Tianjin Pharmaceutical Da Ren Tang Group's Interest Expense for the three months ended in Dec. 2023 was ¥-8 Mil. Tianjin Pharmaceutical Da Ren Tang Group's interest coverage for the quarter that ended in Dec. 2023 was 13.48. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Tianjin Pharmaceutical Da Ren Tang Group's Interest Coverage or its related term are showing as below:

SHSE:600329' s Interest Coverage Range Over the Past 10 Years
Min: 8.09 Med: 39.64 Max: 85133.43
Current: 24.22

SHSE:600329's Interest Coverage is ranked better than
61.01% of 690 companies
in the Drug Manufacturers industry
Industry Median: 12.26 vs SHSE:600329: 24.22

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Tianjin Pharmaceutical Da Ren Tang Group Interest Coverage Historical Data

The historical data trend for Tianjin Pharmaceutical Da Ren Tang Group's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Tianjin Pharmaceutical Da Ren Tang Group Interest Coverage Chart

Tianjin Pharmaceutical Da Ren Tang Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Coverage

Get a 7-Day Free Trial

115.69

85,133.43

208.78

70.44

24.22

Tianjin Pharmaceutical Da Ren Tang Group Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Interest Coverage	Get a 7-Day Free Trial															14.69	43.98	28.48	13.96	13.48

Competitive Comparison of Tianjin Pharmaceutical Da Ren Tang Group's Interest Coverage

For the Drug Manufacturers - Specialty & Generic subindustry, Tianjin Pharmaceutical Da Ren Tang Group's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tianjin Pharmaceutical Da Ren Tang Group's Interest Coverage Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tianjin Pharmaceutical Da Ren Tang Group's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Tianjin Pharmaceutical Da Ren Tang Group's Interest Coverage falls into.

Tianjin Pharmaceutical Da Ren Tang Group Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage

-1

Operating Income

Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt ⁽¹⁾.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Tianjin Pharmaceutical Da Ren Tang Group's Interest Coverage for the fiscal year that ended in Dec. 2023 is calculated as

Here, for the fiscal year that ended in Dec. 2023, Tianjin Pharmaceutical Da Ren Tang Group's Interest Expense was ¥-36 Mil. Its Operating Income was ¥868 Mil. And its Long-Term Debt & Capital Lease Obligation was ¥244 Mil.

Interest Coverage	=	-1	*	Operating Income (A: Dec. 2023 )	/	Interest Expense (A: Dec. 2023 )
	=	-1	*	868.253	/	-35.853
	=	24.22

Tianjin Pharmaceutical Da Ren Tang Group's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Here, for the three months ended in Dec. 2023, Tianjin Pharmaceutical Da Ren Tang Group's Interest Expense was ¥-8 Mil. Its Operating Income was ¥108 Mil. And its Long-Term Debt & Capital Lease Obligation was ¥244 Mil.

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	108.134	/	-8.024
	=	13.48

The higher the ratio, the stronger the company's Financial Strength is.

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .

Tianjin Pharmaceutical Da Ren Tang Group Interest Coverage Related Terms

Thank you for viewing the detailed overview of Tianjin Pharmaceutical Da Ren Tang Group's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd (SHSE:600329) » Definitions » Interest Coverage

Traded in Other Exchanges

T14:Singapore

Address

No. 17 Baidi Road, Zhong Xin Mansion, Nankai District, Tianjin, CHN, 300193

Website

http://www.jydrt.com.cn

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a pharmaceutical manufacturing company. The company manufactures and sells traditional Chinese medicine, western medicine, and healthcare products in the People's Republic of China. It operates in two segments namely The Chinese Medicine segment and The Western Medicine segment. The Chinese Medicine segment manufactures Chinese pharmaceutical products under brands owned by the group. The Western Medicine segment manufactures western pharmaceutical products through cooperation with foreign companies. The company earns the majority of its revenue from the sale of Chinese pharmaceutical products.

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Headlines

No Headlines